Insmed | 营业费用

Operating Expenses 更改 日
Cytokinetics USD 129.09M 6.45M 2023-12
Dynavax Technologies USD 64.09M 311K 2023-12
Gilead Sciences USD 5.5B 1.08B 2023-12
Insmed USD 261.96M 35.22M 2023-12
Regeneron Pharmaceuticals USD 2.46B 209.7M 2023-12
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
Vertex Pharmaceuticals USD 1.45B 21.4M 2023-09



Insmed 营业费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.